Lussana, F.; Caprioli, C.; Stefanoni, P.; Pavoni, C.; Spinelli, O.; Buklijas, K.; Michelato, A.; Borleri, G.; Algarotti, A.; Micò, C.;
et al. Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers 2019, 11, 1455.
https://doi.org/10.3390/cancers11101455
AMA Style
Lussana F, Caprioli C, Stefanoni P, Pavoni C, Spinelli O, Buklijas K, Michelato A, Borleri G, Algarotti A, Micò C,
et al. Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers. 2019; 11(10):1455.
https://doi.org/10.3390/cancers11101455
Chicago/Turabian Style
Lussana, Federico, Chiara Caprioli, Paola Stefanoni, Chiara Pavoni, Orietta Spinelli, Ksenija Buklijas, Anna Michelato, GianMaria Borleri, Alessandra Algarotti, Caterina Micò,
and et al. 2019. "Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia" Cancers 11, no. 10: 1455.
https://doi.org/10.3390/cancers11101455
APA Style
Lussana, F., Caprioli, C., Stefanoni, P., Pavoni, C., Spinelli, O., Buklijas, K., Michelato, A., Borleri, G., Algarotti, A., Micò, C., Grassi, A., Intermesoli, T., & Rambaldi, A.
(2019). Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers, 11(10), 1455.
https://doi.org/10.3390/cancers11101455
